MCRS1 Expression Regulates Tumor Activity and Affects Survival Probability of Patients with Gastric Cancer

Gastric cancer is the fifth most common cancer worldwide and the third most common cause of cancer-related deaths. Surgery remains the first-choice treatment. Chemotherapy is considered in the middle and advanced stages, but has limited success. Microspherule protein 1 (MCRS1, also known as MSP58) is a protein originally identified in the nucleus and cytoplasm that is involved in the cell cycle. High expression of MCRS1 increases tumor growth, invasiveness, and metastasis. The mechanistic relationships between MCSR1 and proliferation, apoptosis, angiogenesis, and epithelial–mesenchymal transition (EMT) remain to be elucidated. We clarified these relationships using immunostaining of tumor tissues and normal tissues from patients with gastric cancer. High MCRS1 expression in gastric cancer positively correlated with Ki-67, Caspase3, CD31, Fibronectin, pAKT, and pAMPK. The hazard ratio of high MCRS1 expression was 2.44 times that of low MCRS1 expression, negatively impacting patient survival.

[1]  Mengqiao Wang,et al.  Hsa_circ_0000285 contributes to gastric cancer progression by upregulating FN1 through the inhibition of miR‐1278 , 2022, Journal of clinical laboratory analysis.

[2]  Yen-Lin Chen,et al.  High Mobility Group A 1 Expression as a Poor Prognostic Marker Associated with Tumor Invasiveness in Gastric Cancer , 2022, Life.

[3]  Yan Chen,et al.  B7-H3 inhibits apoptosis of gastric cancer cell by interacting with Fibronectin , 2021, Journal of Cancer.

[4]  Biqing Chen,et al.  MiR-10b-5p inhibits tumorigenesis in gastric cancer xengograft mice model through down-regulating Tiam1. , 2021, Experimental cell research.

[5]  A. von Au,et al.  Inhibition of fibronectin accumulation suppresses TUMOR growth , 2021, Neoplasia.

[6]  Zhibin Chen,et al.  Autoimmunity as an Etiological Factor of Cancer: The Transformative Potential of Chronic Type 2 Inflammation , 2021, Frontiers in Cell and Developmental Biology.

[7]  I. Vlodavsky,et al.  Role of heparanase 2 (Hpa2) in gastric cancer , 2021, Neoplasia.

[8]  Li-Bin Li,et al.  Oral glutamine inhibits tumor growth of gastric cancer bearing mice by improving immune function and activating apoptosis pathway. , 2021, Tissue & cell.

[9]  M. Trněný,et al.  CD31/PECAM-1 impacts engraftment, growth and spread of mantle cell lymphoma cells and positively correlates with extramedullary involvement , 2020, Leukemia & lymphoma.

[10]  W. Hwu,et al.  Pathology-based Biomarkers Useful for Clinical Decisions in Melanoma. , 2020, Archives of medical research.

[11]  Y. Li,et al.  Serum CXCL13 and PECAM-1 can be used as diagnostic and prognostic markers in elderly patients with gastric cancer , 2020, Clinical and Translational Oncology.

[12]  Shanming Ruan,et al.  Long non-coding RNAs towards precision medicine in gastric cancer: early diagnosis, treatment, and drug resistance , 2020, Molecular Cancer.

[13]  Shijie Cao,et al.  Berberine represses human gastric cancer cell growth in vitro and in vivo by inducing cytostatic autophagy via inhibition of MAPK/mTOR/p70S6K and Akt signaling pathways. , 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[14]  D. He,et al.  Astragalus Polysaccharide Promotes Adriamycin-Induced Apoptosis in Gastric Cancer Cells , 2020, Cancer management and research.

[15]  F. Bazzoli,et al.  Gastric cancer prevention strategies: A global perspective , 2020, Journal of gastroenterology and hepatology.

[16]  K. Anderson,et al.  The Epithelial-to-Mesenchymal Transition (EMT) in Development and Cancer. , 2020, Annual review of cancer biology.

[17]  H. El‐Serag,et al.  Burden of Gastric Cancer. , 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[18]  Wei Cui,et al.  MCRS1 is essential for epiblast development during early mouse embryogenesis. , 2020, Reproduction.

[19]  Fan Dang,et al.  β-Cryptoxanthin induced anti-proliferation and apoptosis by G0/G1 arrest and AMPK signal inactivation in gastric cancer. , 2019, European journal of pharmacology.

[20]  Zhen-ke Wen,et al.  Apatinib suppresses the Proliferation and Apoptosis of Gastric Cancer Cells via the PI3K/Akt Signaling Pathway. , 2019, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

[21]  Lili Ren,et al.  Effects of MCRS1 on proliferation, migration, invasion, and epithelial mesenchymal transition of gastric cancer cells by interacting with Pkmyt1 protein kinase. , 2019, Cellular signalling.

[22]  Yingliang Ou,et al.  miR‐186 modulates hepatocellular carcinoma cell proliferation and mobility via targeting MCRS1‐mediated Wnt/β‐catenin signaling , 2019, Journal of cellular physiology.

[23]  Shiling Zhao,et al.  Ketamine exhibits anti-gastric cancer activity via induction of apoptosis and attenuation of PI3K/Akt/mTOR , 2019, Archives of medical science : AMS.

[24]  Z-P Tan.  Recent Advances in the Surgical Treatment of Advanced Gastric Cancer: A Review , 2019, Medical science monitor : international medical journal of experimental and clinical research.

[25]  C. Guruvayoorappan,et al.  Ki-67 protein as a tumour proliferation marker. , 2019, Clinica chimica acta; international journal of clinical chemistry.

[26]  H. Ibrahim,et al.  Role of VEGF, CD105, and CD31 in the Prognosis of Colorectal Cancer Cases , 2019, Journal of Gastrointestinal Cancer.

[27]  Prashanth Rawla,et al.  Epidemiology of gastric cancer: global trends, risk factors and prevention , 2018, Przeglad gastroenterologiczny.

[28]  Y. Zou,et al.  miR‑101 regulates the cell proliferation and apoptosis in diffuse large B‑cell lymphoma by targeting MEK1 via regulation of the ERK/MAPK signaling pathway. , 2018, Oncology reports.

[29]  R. Weinberg,et al.  New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer , 2018, Nature reviews. Molecular cell biology.

[30]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[31]  Xiao-dong Zhu,et al.  CD31 regulates metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinoma via the ITGB1-FAK-Akt signaling pathway. , 2018, Cancer letters.

[32]  Jing-Ping Liu,et al.  Effects of Fibronectin 1 on Cell Proliferation, Senescence and Apoptosis of Human Glioma Cells Through the PI3K/AKT Signaling Pathway , 2018, Cellular Physiology and Biochemistry.

[33]  Xiaojun Xu,et al.  Osthole inhibits gastric cancer cell proliferation through regulation of PI3K/AKT , 2018, PloS one.

[34]  P. Kaufman,et al.  Ki-67: more than a proliferation marker , 2018, Chromosoma.

[35]  S. Rodríguez-Perales,et al.  mTORC1 Inactivation Promotes Colitis-Induced Colorectal Cancer but Protects from APC Loss-Dependent Tumorigenesis. , 2018, Cell metabolism.

[36]  W. Earnshaw,et al.  Ki-67 and the Chromosome Periphery Compartment in Mitosis. , 2017, Trends in cell biology.

[37]  Dong Zhang,et al.  Knockdown of MSP58 inhibits the proliferation and metastasis in human renal cell carcinoma cells. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[38]  Yuanyu Wu,et al.  Progress in the treatment of advanced gastric cancer , 2017, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

[39]  R. Weinberg,et al.  EMT, CSCs, and drug resistance: the mechanistic link and clinical implications , 2017, Nature Reviews Clinical Oncology.

[40]  R. Weinberg,et al.  Emerging Biological Principles of Metastasis , 2017, Cell.

[41]  Cheol‐Hee Kim,et al.  MCRS1 associates with cytoplasmic dynein and mediates pericentrosomal material recruitment , 2016, Scientific Reports.

[42]  Yanfang Jiang,et al.  Expression of MCRS1 and MCRS2 and their correlation with serum carcinoembryonic antigen in colorectal cancer , 2016, Experimental and therapeutic medicine.

[43]  P. Newman,et al.  Endothelial functions of platelet/endothelial cell adhesion molecule-1 (CD31) , 2016, Current opinion in hematology.

[44]  M. Tsai,et al.  The nucleolar protein NIFK promotes cancer progression via CK1α/β-catenin in metastasis and Ki-67-dependent cell proliferation , 2016, eLife.

[45]  T. Tamiya,et al.  Expression of 58-kD Microspherule Protein (MSP58) is Highly Correlated with PET Imaging of Tumor Malignancy and Cell Proliferation in Glioma Patients , 2016, Cellular Physiology and Biochemistry.

[46]  Chenji Wang,et al.  Stabilization of MCRS1 by BAP1 prevents chromosome instability in renal cell carcinoma. , 2015, Cancer letters.

[47]  Yi Cao,et al.  The candidate oncogene (MCRS1) promotes the growth of human lung cancer cells via the miR–155–Rb1 pathway , 2015, Journal of experimental & clinical cancer research : CR.

[48]  T. Yoneda,et al.  Cellular fibronectin 1 promotes VEGF-C expression, lymphangiogenesis and lymph node metastasis associated with human oral squamous cell carcinoma , 2015, Clinical & Experimental Metastasis.

[49]  Zhen-bo Feng,et al.  Prognostic value of Caspase-3 expression in cancers of digestive tract: a meta-analysis and systematic review. , 2015, International journal of clinical and experimental medicine.

[50]  R. Mirzayans,et al.  Characterization of the Apoptotic Response Induced by the Cyanine Dye D112: A Potentially Selective Anti-Cancer Compound , 2015, PloS one.

[51]  M. Tsai,et al.  The RNA recognition motif of NIFK is required for rRNA maturation during cell cycle progression , 2015, RNA biology.

[52]  T. Luukkaala,et al.  VEGFR3 and CD31 as prognostic factors in renal cell cancer. , 2015, Anticancer research.

[53]  L. Bernal-Mizrachi,et al.  A Time to Kill: Targeting Apoptosis in Cancer , 2015, International journal of molecular sciences.

[54]  Yi Cao,et al.  MCRS1 overexpression, which is specifically inhibited by miR-129*, promotes the epithelial-mesenchymal transition and metastasis in non-small cell lung cancer , 2014, Molecular Cancer.

[55]  S. Rayala,et al.  Transcriptional regulation of fibronectin by p21-activated kinase-1 modulates pancreatic tumorigenesis , 2014, Oncogene.

[56]  R. Mirzayans,et al.  Ionizing Radiation-Induced Responses in Human Cells with Differing TP53 Status , 2013, International journal of molecular sciences.

[57]  Sung Yong Oh,et al.  Association between Phosphorylated AMP-Activated Protein Kinase and MAPK3/1 Expression and Prognosis for Patients with Gastric Cancer , 2013, Oncology.

[58]  Chang-sheng Chen,et al.  Expression of MSP58 in hepatocellular carcinoma , 2013, Medical Oncology.

[59]  Yi Cao,et al.  Analysis of 20 genes at chromosome band 12q13: RACGAP1 and MCRS1 overexpression in nonsmall‐cell lung cancer , 2013, Genes, chromosomes & cancer.

[60]  Allon M Klein,et al.  Kinetic Responses of β-Catenin Specify the Sites of Wnt Control , 2012, Science.

[61]  Jing Zhang,et al.  Downregulation of MSP58 suppresses cell proliferation in neuroblastoma cell lines , 2012, Neuroreport.

[62]  H. Chung,et al.  Phosphorylated AMP-activated protein kinase expression associated with prognosis for patients with gastric cancer treated with cisplatin-based adjuvant chemotherapy , 2012, Cancer Chemotherapy and Pharmacology.

[63]  C. Widmann,et al.  Caspase-3 Protects Stressed Organs against Cell Death , 2012, Molecular and Cellular Biology.

[64]  R. Mirzayans,et al.  New Insights into p53 Signaling and Cancer Cell Response to DNA Damage: Implications for Cancer Therapy , 2012, Journal of biomedicine & biotechnology.

[65]  Hans Clevers,et al.  Wnt Signaling through Inhibition of β-Catenin Degradation in an Intact Axin1 Complex , 2012, Cell.

[66]  I. Vernos,et al.  K-fibre minus ends are stabilized by a RanGTP-dependent mechanism essential for functional spindle assembly , 2011, Nature Cell Biology.

[67]  E. White,et al.  Fibronectin splice variants: Understanding their multiple roles in health and disease using engineered mouse models , 2011, IUBMB life.

[68]  A. Jimeno,et al.  Caspase 3-mediated stimulation of tumor cell repopulation during cancer radiotherapy , 2011, Nature Medicine.

[69]  W. Jonat,et al.  Is the Ki-67 labelling index ready for clinical use? , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

[70]  E. Lengyel,et al.  Ligand independent activation of c-Met by fibronectin and α5β1-integrin regulates ovarian cancer invasion and metastasis , 2010, Oncogene.

[71]  H. DeLisser,et al.  Angiogenesis in platelet endothelial cell adhesion molecule-1-null mice. , 2009, The American journal of pathology.

[72]  J. Bai,et al.  Characterisation of fibronectin-mediated FAK signalling pathways in lung cancer cell migration and invasion , 2009, British Journal of Cancer.

[73]  J. Pouysségur,et al.  Total ERK1/2 activity regulates cell proliferation , 2009, Cell cycle.

[74]  Hua Han,et al.  RNAi-mediated inhibition of MSP58 decreases tumour growth, migration and invasion in a human glioma cell line , 2008, Journal of cellular and molecular medicine.

[75]  D. Livant,et al.  Role of focal adhesion kinase and phosphatidylinositol 3'-kinase in integrin fibronectin receptor-mediated, matrix metalloproteinase-1-dependent invasion by metastatic prostate cancer cells. , 2006, Cancer research.

[76]  S. Han,et al.  Fibronectin induces cell proliferation and inhibits apoptosis in human bronchial epithelial cells: pro-oncogenic effects mediated by PI3-kinase and NF-κB , 2006, Oncogene.

[77]  H. DeLisser,et al.  Role of immunoreceptor tyrosine-based inhibitory motifs of PECAM-1 in PECAM-1-dependent cell migration. , 2004, American journal of physiology. Cell physiology.

[78]  M. Sawada,et al.  PECAM-1 functions as a specific and potent inhibitor of mitochondrial-dependent apoptosis. , 2003, Blood.

[79]  H. Shih,et al.  Essential Role of the 58-kDa Microspherule Protein in the Modulation of Daxx-dependent Transcriptional Repression as Revealed by Nucleolar Sequestration* , 2002, The Journal of Biological Chemistry.

[80]  H. Chung,et al.  Hypoxia-induced VEGF enhances tumor survivability via suppression of serum deprivation-induced apoptosis , 2000, Oncogene.

[81]  M. Gerritsen,et al.  Functional roles for PECAM-1 (CD31) and VE-cadherin (CD144) in tube assembly and lumen formation in three-dimensional collagen gels. , 1999, The American journal of pathology.

[82]  R. Wickremasinghe,et al.  Monocytes stimulate expression of the Bcl-2 family member, A1, in endothelial cells and confer protection against apoptosis. , 1999, Journal of immunology.

[83]  J. Gerdes,et al.  The cell proliferation-associated antigen of antibody Ki-67: a very large, ubiquitous nuclear protein with numerous repeated elements, representing a new kind of cell cycle-maintaining proteins , 1993, The Journal of cell biology.

[84]  J. Gorski,et al.  PECAM-1 (CD31) cloning and relation to adhesion molecules of the immunoglobulin gene superfamily. , 1990, Science.

[85]  H Stein,et al.  Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. , 1984, Journal of immunology.

[86]  H. Xi,et al.  Increased Expression of 58-kDa Microspherule Protein (MSP58) in Human Gastric Cancer Promotes Cell Proliferation and Correlates with Poor Patient Survival. , 2016, Clinical laboratory.

[87]  Jean Paul Thiery,et al.  EMT: 2016 , 2016, Cell.

[88]  Yan Wu,et al.  AMPK activator AICAR promotes 5-FU-induced apoptosis in gastric cancer cells , 2015, Molecular and Cellular Biochemistry.

[89]  Jinsong Zhang,et al.  The novel interaction between microspherule protein Msp58 and ubiquitin E3 ligase EDD regulates cell cycle progression. , 2013, Biochimica et biophysica acta.

[90]  A. Gavrish,et al.  [The structural-metabolic damages to the myocardium in acute coronary failure]. , 1998, Likars'ka sprava.